These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36988333)

  • 1. Predictors of damage accrual in patients with antineutrophil cytoplasmic antibody-associated vasculitis: A nationwide prospective study.
    Hara A; Sada KE; Wada T; Amano K; Dobashi H; Atsumi T; Sugihara T; Hirayama K; Banno S; Murakawa Y; Hasegawa M; Yamagata K; Arimura Y; Makino H; Harigai M
    Mod Rheumatol; 2024 Feb; 34(2):382-390. PubMed ID: 36988333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors for Relapse of Antineutrophil Cytoplasmic Antibody-associated Vasculitis in Japan: A Nationwide, Prospective Cohort Study.
    Hara A; Wada T; Sada KE; Amano K; Dobashi H; Harigai M; Takasaki Y; Yamada H; Hasegawa H; Hayashi T; Fujimoto S; Muso E; Kawakami T; Homma S; Yoshida M; Hirahashi J; Ogawa N; Ito S; Makino H; Arimura Y;
    J Rheumatol; 2018 Apr; 45(4):521-528. PubMed ID: 29419469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of tissue inhibitor of metalloproteinase 1 as a predictor of sustained remission in patients with antineutrophil cytoplasmic antibody-associated vasculitis.
    Ishizaki J; Takemori A; Horie K; Hiraoka D; Suemori K; Matsumoto T; Sada KE; Amano K; Harigai M; Arimura Y; Makino H; Takenaka K; Takemori N; Hasegawa H;
    Arthritis Res Ther; 2021 Mar; 23(1):91. PubMed ID: 33743769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment-related damage in elderly-onset ANCA-associated vasculitis: safety outcome analysis of two nationwide prospective cohort studies.
    Sada KE; Ohashi K; Asano Y; Hayashi K; Morishita M; Watanabe H; Matsumoto Y; Fujimoto S; Takasaki Y; Yamagata K; Banno S; Dobashi H; Amano K; Harigai M; Arimura Y; Makino H;
    Arthritis Res Ther; 2020 Oct; 22(1):236. PubMed ID: 33046139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale of concomitant cyclophosphamide for remission-induction in patients with antineutrophil cytoplasmic antibody-associated vasculitis: A propensity score-matched analysis of two nationwide prospective cohort studies.
    Watanabe H; Sada KE; Matsumoto Y; Harigai M; Amano K; Fujimoto S; Dobashi H; Yuzawa Y; Yamagata K; Muso E; Arimura Y; Makino H
    Mod Rheumatol; 2021 Jan; 31(1):205-213. PubMed ID: 31859544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of and risk factors for serious infection in Japanese patients within six months of remission induction therapy for antineutrophil cytoplasmic antibody-associated vasculitis registered in a nationwide, prospective, inception cohort study.
    Watanabe-Imai K; Harigai M; Sada KE; Yamamura M; Fujii T; Dobashi H; Amano K; Ito S; Homma S; Kumagai S; Banno S; Arimura Y; Makino H;
    Mod Rheumatol; 2017 Jul; 27(4):646-651. PubMed ID: 27538706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised controlled trial of prolonged treatment in the remission phase of ANCA-associated vasculitis.
    Karras A; Pagnoux C; Haubitz M; Groot K; Puechal X; Tervaert JWC; Segelmark M; Guillevin L; Jayne D;
    Ann Rheum Dis; 2017 Oct; 76(10):1662-1668. PubMed ID: 28546260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial.
    Sanders JS; de Joode AA; DeSevaux RG; Broekroelofs J; Voskuyl AE; van Paassen P; Kallenberg CG; Tervaert JW; Stegeman CA
    Nephrol Dial Transplant; 2016 Sep; 31(9):1453-9. PubMed ID: 27242368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential Therapy for Remission Induction in Severe Antineutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis.
    Kant S; Habbach A; Gapud EJ; Manno RL; Gattu R; Seo P; Geetha D
    Am J Nephrol; 2019; 50(5):386-391. PubMed ID: 31593967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of severity classification in Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study.
    Sada KE; Harigai M; Amano K; Atsumi T; Fujimoto S; Yuzawa Y; Takasaki Y; Banno S; Sugihara T; Kobayashi M; Usui J; Yamagata K; Homma S; Dobashi H; Tsuboi N; Ishizu A; Sugiyama H; Okada Y; Arimura Y; Matsuo S; Makino H;
    Mod Rheumatol; 2016 Sep; 26(5):730-7. PubMed ID: 26873424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of anti-neutrophil cytoplasmic antibody-associated vasculitis with anti-glomerular basement membrane antibodies that was successfully treated with mizoribine as a safe and effective remission maintenance therapy with prednisolone and plasma exchange.
    Ikeda Y; Fukunari K; Uchiumi S; Awanami Y; Kanaya A; Matsumoto K; Fukuda M; Takashima T; Miyazono M; Ikeda Y
    CEN Case Rep; 2020 Feb; 9(1):42-47. PubMed ID: 31612361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized Controlled Study.
    Jayne D; Blockmans D; Luqmani R; Moiseev S; Ji B; Green Y; Hall L; Roth D; Henderson RB; Merkel PA;
    Arthritis Rheumatol; 2019 Jun; 71(6):952-963. PubMed ID: 30666823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis: the JMAAV study.
    Ozaki S; Atsumi T; Hayashi T; Ishizu A; Kobayashi S; Kumagai S; Kurihara Y; Kurokawa MS; Makino H; Nagafuchi H; Nakabayashi K; Nishimoto N; Suka M; Tomino Y; Yamada H; Yamagata K; Yoshida M; Yumura W; Amano K; Arimura Y; Hatta K; Ito S; Kikuchi H; Muso E; Nakashima H; Ohsone Y; Suzuki Y; Hashimoto H; Koyama A; Matsuo S; Kato H
    Mod Rheumatol; 2012 Jun; 22(3):394-404. PubMed ID: 21928092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Outcomes in Children With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Morishita KA; Moorthy LN; Lubieniecka JM; Twilt M; Yeung RSM; Toth MB; Shenoi S; Ristic G; Nielsen SM; Luqmani RA; Li SC; Lee T; Lawson EF; Kostik MM; Klein-Gitelman M; Huber AM; Hersh AO; Foell D; Elder ME; Eberhard BA; Dancey P; Charuvanij S; Benseler SM; Cabral DA;
    Arthritis Rheumatol; 2017 Jul; 69(7):1470-1479. PubMed ID: 28371513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes.
    Monti S; Craven A; Klersy C; Montecucco C; Caporali R; Watts R; Merkel PA; Luqmani R;
    Rheumatology (Oxford); 2021 Feb; 60(2):617-628. PubMed ID: 32447389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Lupus Anticoagulant With Long-Term Damage Accrual in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Jordan N; D'cruz DP
    Arthritis Care Res (Hoboken); 2016 May; 68(5):711-5. PubMed ID: 26415137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in the treatment strategy for AAV improved outcomes with intensive GC tapering.
    Ono N; Kai T; Takeyama Y; Inoue Y; Ueda N; Nagano S; Ohta S; Inoue H; Sawabe T; Chifu Y; Yoshizawa S; Oryoji K; Kimoto Y; Miyake K; Ayano M; Mitoma H; Arinobu Y; Miyamura T; Horiuchi T; Akashi K; Tada Y; Niiro H
    Int J Rheum Dis; 2024 Jan; 27(1):e15009. PubMed ID: 38129977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Earliest total vascular damage index scores independently predict all-cause mortality in patients with ANCA-associated vasculitis.
    Koo G; Ha JW; Ahn SS; Song JJ; Park YB; Lee SW
    Clin Exp Rheumatol; 2024 Apr; 42(4):795-802. PubMed ID: 38179702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of Microscopic Hematuria after Induction of Remission in Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis.
    Vandenbussche C; Bitton L; Bataille P; Glowacki F; Azar R; Hatron PY; Macnamara E; Gheerbrant JD; Cardon G; Hoffmann M; Auxenfants E; Gnemmi V; Quéméneur T
    Am J Nephrol; 2019; 49(6):479-486. PubMed ID: 31117066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remission and Low Disease Activity in Granulomatosis With Polyangiitis and Microscopic Polyangiitis: Prevalence and Impact on Damage Accrual.
    Delvino P; Sardanelli F; Monti S; Cohen P; Puéchal X; Mouthon L; Montecucco C; Guillevin L; Terrier B
    Arthritis Care Res (Hoboken); 2023 May; 75(5):1158-1165. PubMed ID: 35604889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.